glutamic acid has been researched along with ketanserin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Dixon, JF; Hokin, LE; Sastry, PS | 1 |
| Hansson, E; Nilsson, M; Rönnbäck, L | 1 |
| Duran, M; Samochocki, M; Strosznajder, J | 1 |
| Gong, CL; Kuo, JS; Lin, NN | 1 |
| Chang, CP; Chen, SH; Lin, MT | 1 |
| Sihra, TS; Wang, KY; Wang, SJ; Wang, WC | 1 |
| Anneken, JH; Gudelsky, GA | 1 |
| Ganev, EG; Hiruma-Lima, CA; Martins, DF; Mazzardo-Martins, L; Nishijima, CM; Rocha, LR; Santos, AR | 1 |
| Buchborn, T; Dieterich, DC; Grecksch, G; Höllt, V; Schröder, H | 1 |
13 other study(ies) available for glutamic acid and ketanserin
| Article | Year |
|---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Agonist-stimulated inositol polyphosphate formation in cerebellum.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Cerebellum; Glutamates; Glutamic Acid; Guinea Pigs; In Vitro Techniques; Inositol Phosphates; Isomerism; Ketanserin; Male; Osmolar Concentration; Quinoxalines; Quisqualic Acid; Serotonin; Time Factors | 1992 |
Receptor-coupled uptake of valproate in rat astroglial primary cultures.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Astrocytes; Biological Transport; Cells, Cultured; Cerebral Cortex; Clonidine; Drug Interactions; Glutamates; Glutamic Acid; Isoproterenol; Kainic Acid; Ketanserin; Phenylephrine; Prazosin; Quinoxalines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Serotonin; Valproic Acid; Yohimbine | 1992 |
Serotonin, a potent modulator of arachidonic acid turnover, interaction with glutamatergic receptor in brain cortex.
Topics: Animals; Arachidonic Acid; Buspirone; Cerebral Cortex; Glutamic Acid; Ketanserin; Lysophospholipids; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Rats; Receptors, Glutamate; Serotonin; Synaptosomes | 1994 |
Glutamatergic and serotonergic mechanisms in the dorsal facial area for common carotid artery blood flow control in the cat.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamines; Animals; Blood Flow Velocity; Blood Pressure; Carotid Artery, Common; Cats; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Female; Glutamates; Glutamic Acid; Heart Rate; Ketanserin; Male; Medulla Oblongata; Microinjections; N-Methylaspartate; Receptors, AMPA; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |
Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke.
Topics: Anesthesia; Animals; Brain; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Glutamic Acid; Glycerol; Heat Stroke; Hot Temperature; Hypertension; Hypoxia; Intracranial Hypertension; Ketanserin; Lactates; Lactic Acid; Models, Statistical; Neurons; Oxygen; Pressure; Pyrimidines; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Receptor Agonists; Shock; Temperature; Time Factors; Titanium; Urethane | 2005 |
Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Topics: Amphetamines; Animals; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dicarboxylic Acids; Drug Interactions; Enzyme Inhibitors; Glutamic Acid; Ketanserin; Male; Membrane Potentials; Neural Inhibition; Neurotransmitter Uptake Inhibitors; omega-Agatoxin IVA; omega-Conotoxin GVIA; Presynaptic Terminals; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides; Synaptosomes; Time Factors | 2006 |
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Chromatography, High Pressure Liquid; Extracellular Space; Fluoxetine; Glutamic Acid; Hippocampus; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sodium Channel Blockers; Tetrodotoxin | 2012 |
Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain.
Topics: Acute Pain; Acyclic Monoterpenes; Analgesics; Animals; Capsaicin; Chronic Pain; Excitatory Amino Acids; Formaldehyde; Glutamic Acid; Hyperalgesia; Ischemia; Ketanserin; Male; Mice; Monoterpenes; Neuralgia; Pain, Postoperative; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Stomach Ulcer; Substance P; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |
Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Topics: Animals; Binding Sites; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Tolerance; Frontal Lobe; Glutamic Acid; Hallucinogens; Ketanserin; Lysergic Acid Diethylamide; Male; Motor Activity; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Glutamate; Serotonin Antagonists | 2015 |